Interact with CNBC-TV18: Pharma sector doing well, will continue to do so: Hiren Ved

Moneycontrol boarder Shailendra from Mumbai asks Hiren Ved, Director & CIO, Alchemy Capital Management, whether it would be advisable to buy in to the pharmaceutical sector at current levels.

Ved says he doesn’t look at pharmaceutical as defensive or non defensive. He says the sector is doing extremely well and growth will continue irrespective. It is not as if the new government comes and the pharma sector will have no scope for growth and appreciation, he adds.

"So, it is a secular growth story in India, just like how you talk about consumer as being a secular growth story in India; pharma is a secular growth story. We have a global competitive advantage in that sector and companies will continue to do well over the next two-three years. So, it is a good long-term sector to be in and one will have to stock specific," Ved says.

There are a few good high quality largecap names, but you also have some midcap companies which have done phenomenally well and are growing at 20-25 percent and profit. He advises Shailendra to take a stock by stock call but it is a great sector to be invested in.